Impl investor relations
WitrynaVice President, Investor Relations (281) 836-8360 [email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email … WitrynaOur Investment Case ... Download Read online. Investor Contacts. Raghav Gupta-Chaudhary. Investor Relations Director +44 (0)20 7546 8235 [email protected] Related pages. 2024 Financial Performance. Financial calendar. Quick Links. Our story; Our approach; Responsibility; Investors; Careers; Contact; Menu Item;
Impl investor relations
Did you know?
Witryna5 kwi 2024 · Founded. 2008. Impel Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. It engages in the development and commercialization of … Witryna2 dni temu · H. Stewart Parker Departing from BoardSEATTLE, April 12, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative ...
Witryna17 mar 2024 · Corporate Profile. Impel Pharmaceuticals is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules and … Investor Calendar Past Events. Mar 24, 2024 8:30 AM EDT Impel Pharmaceutic… Impel's SEC filings can be viewed on the Financial Information portion of our Inv… Witryna10 mar 2024 · March 03 2024 - 04:01PM. GlobeNewswire Inc. Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced that the Company will participate in two upcoming investor …
WitrynaThe Investor Relations website contains information about Mission Produce, Inc.'s business for stockholders, potential investors, and financial analysts. Witryna17 lut 2024 · 17.02.2024. Download report Implantica publishes Year-end Report, January – December 2024 (Q4)
Witryna22 lut 2024 · Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, March 24, 2024. SEATTLE, March 17, 2024 (GLOBE …
Witryna3 mar 2024 · Media Relations: Melyssa Weible Elixir Health Public Relations Phone: (1) 386-366-0616 Email: [email protected]. Investor Relations Janhavi … eastern lock and key ashlandWitrynaImpel's SEC filings can be viewed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov. Whom should I contact regarding investor inquiries? You can submit queries to Impel's investor relations department by contacting (206) 568-1466 or [email protected] . eastern local schools meigs county ohioWitryna15 lis 2024 · Impel to Host Investor Conference Call Today at 8:30 a.m. ET. SEATTLE, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a … eastern locksmith goldsboroWitryna17 lut 2024 · Investor Relations - IR: Investor relations (IR) is a department, present in most medium-to-large public companies , that provides investors with an accurate account of company affairs. This helps ... eastern local schools reedsville ohioWitryna18 sty 2024 · Investor Relations. Press Releases; Events; Events. Get News Alerts by Email. GO Upcoming Events Past Events; March 2024 March 6, 2024 - March 8, 2024 8:00am - 5:00pm EST Listen to the Webcast. TD Cowen 43rd Annual Health Care Conference. Cardiff Oncology management will participate in a corporate panel … cu highlands ranch hospitalWitryna40–50%. >50%. Renewable energy plays an important and growing role in the energy system of the European Union. The Europe 2024 strategy included a target of reaching 20% of gross final energy consumption from renewable sources by 2024, and at least 32% by 2030. [15] The EU27 reached 22% in 2024, up from 9.6% in 2004. cu high boyWitryna13 lip 2024 · Investor Relations. Corporate Profile. RenovoRx, a biopharmaceutical company headquartered in Silicon Valley, California, ... Investors; Contact; Delivering Therapy Where it Matters. 4546 El Camino Real, Suite B1 Los Altos, CA 94022 (650) 284-4433 (650) 397-4433. Quicklinks. About; Clinical Trials; eastern lodge b\u0026b